Total Payments
$11,728
2024 Payments
$110.98
Companies
40
Transactions
460
Medicare Patients
9,654
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$7,137 (60.9%)
Other$3,800 (32.4%)
Travel$756.36 (6.4%)
Education$34.44 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,137 | 452 | 60.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,800 | 1 | 32.4% |
| Travel and Lodging | $756.36 | 4 | 6.4% |
| Education | $34.44 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ethicon Inc. | $4,612 | 8 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,092 | 65 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,037 | 91 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $884.12 | 55 | $0 (2022) |
| Electromed, Inc. | $423.85 | 40 | $0 (2022) |
| Genentech USA, Inc. | $361.96 | 25 | $0 (2022) |
| Philips Electronics North America Corporation | $341.81 | 13 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $337.30 | 20 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $307.85 | 16 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $295.75 | 32 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $110.98 | 5 | AstraZeneca Pharmaceuticals LP ($110.98) |
| 2023 | $54.17 | 3 | AstraZeneca Pharmaceuticals LP ($33.72) |
| 2022 | $1,157 | 65 | Boehringer Ingelheim Pharmaceuticals, Inc. ($205.22) |
| 2021 | $5,755 | 71 | Ethicon Inc. ($4,594) |
| 2020 | $790.49 | 49 | AstraZeneca Pharmaceuticals LP ($202.12) |
| 2019 | $1,299 | 89 | GlaxoSmithKline, LLC. ($178.93) |
| 2018 | $1,464 | 105 | GlaxoSmithKline, LLC. ($332.73) |
| 2017 | $1,097 | 73 | GlaxoSmithKline, LLC. ($203.02) |
All Payment Transactions
460 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Respiratory | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Respiratory | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Respiratory | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Respiratory | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Respiratory | ||||||
| 05/03/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.53 | General |
| 01/17/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $20.45 | General |
| Category: Medical Device | ||||||
| 12/20/2022 | Pulmonx Corporation | ZEPHYR DELIVERY CATHETER (Device), ZEPHYR ENDOBRONCHIAL VALVE, PULMONX CHARTIS TABLET CONSOLE | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: PULMONOLOGY | ||||||
| 12/07/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.43 | General |
| Category: HFCWO | ||||||
| 11/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2022 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: Neurological Disorders | ||||||
| 10/21/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: NEUROLOGY | ||||||
| 10/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: RESPIRATORY | ||||||
| 10/19/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2022 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Immunology | ||||||
| 10/13/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Cardiology | ||||||
| 10/13/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $10.16 | General |
| Category: HFCWO | ||||||
| 10/11/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV, OFEV | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.72 | General |
| Category: HFCWO | ||||||
| 09/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Pulmonology | ||||||
| 09/06/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Cardiology | ||||||
| 09/01/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 963 | 1,032 | $175,067 | $66,952 |
| 2022 | 20 | 2,574 | 3,153 | $645,530 | $259,937 |
| 2021 | 20 | 3,132 | 4,179 | $832,637 | $344,044 |
| 2020 | 19 | 2,985 | 4,054 | $865,595 | $351,444 |
Total Patients
9,654
Total Services
12,418
Medicare Billing
$1.0M
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 157 | $38,308 | $15,958 | 41.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 92 | 100 | $32,900 | $14,232 | 43.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $23,998 | $9,217 | 38.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 169 | 174 | $21,402 | $8,093 | 37.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 152 | 154 | $19,096 | $6,868 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $11,928 | $4,917 | 41.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 115 | 117 | $15,912 | $3,707 | 23.3% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 54 | 56 | $4,984 | $1,753 | 35.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 57 | 63 | $4,851 | $1,701 | 35.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 12 | 12 | $972.00 | $263.64 | 27.1% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 15 | 15 | $675.00 | $233.25 | 34.6% |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | Office | 2023 | 80 | 85 | $40.64 | $8.91 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 589 | 750 | $146,250 | $69,794 | 47.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 139 | 337 | $50,550 | $27,387 | 54.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 53 | 53 | $63,600 | $25,298 | 39.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 65 | 135 | $70,875 | $23,727 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 137 | 161 | $48,300 | $22,199 | 46.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 87 | 90 | $25,650 | $14,171 | 55.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 23 | 24 | $24,000 | $10,843 | 45.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 89 | 184 | $19,320 | $10,398 | 53.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 209 | 211 | $27,430 | $8,979 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $19,345 | $8,767 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 128 | 132 | $13,200 | $8,333 | 63.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 205 | 207 | $26,910 | $7,976 | 29.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 227 | 230 | $46,000 | $6,431 | 14.0% |
About Dr. John Wade, MD
Dr. John Wade, MD is a Critical Care Medicine healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699799692.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Wade, MD has received a total of $11,728 in payments from pharmaceutical and medical device companies, with $110.98 received in 2024. These payments were reported across 460 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,137).
As a Medicare-enrolled provider, Wade has provided services to 9,654 Medicare beneficiaries, totaling 12,418 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Denver, CO
- Active Since 07/26/2006
- Last Updated 04/24/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1699799692
Products in Payments
- Monarch Platform (Device) $4,594
- OFEV (Drug) $606.84
- NUCALA (Biological) $515.70
- SMARTVEST (Device) $423.85
- ORENITRAM (Drug) $268.83
- TRELEGY ELLIPTA (Drug) $268.51
- BREZTRI (Drug) $245.01
- BEVESPI AEROSPHERE (Drug) $236.81
- Xolair (Biological) $218.89
- XYWAV (Drug) $215.99
- AVYCAZ (Drug) $204.39
- DUPIXENT (Biological) $180.51
- FASENRA (Biological) $152.79
- LONHALA MAGNAIR (Drug) $145.12
- Esbriet (Biological) $143.07
- UPTRAVI (Drug) $135.61
- remede System (Device) $131.21
- FASENRA (Drug) $127.93
- OPSUMIT (Drug) $126.92
- STIOLTO RESPIMAT (Drug) $125.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Denver
Michael Wechsler, Md, MD
Critical Care Medicine — Payments: $2.8M
Critical Care Medicine $2.8M
Dr. Rebecca Keith, M.d, M.D
Critical Care Medicine — Payments: $264,380
Critical Care Medicine $264,380
Marjorie George, Md, MD
Critical Care Medicine — Payments: $227,937
Critical Care Medicine $227,937
Charles Daley, Md, MD
Critical Care Medicine — Payments: $150,259
Critical Care Medicine $150,259
Zulma Yunt, Md, MD
Critical Care Medicine — Payments: $93,837
Critical Care Medicine $93,837
Dr. Timmy Lahm, Md, MD
Critical Care Medicine — Payments: $54,623
Critical Care Medicine $54,623